Cranberry proanthocyanidins: Natural weapons against periodontal diseases

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 23, 2012, Pages 5728-5735

  Feghali, Karine ^a   Feldman, Mark ^a   La, Vu Dang ^a   Santos, Juliana ^a   Grenier, Daniel ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

bacteria; cranberry; cytokine; matrix metalloproteinase; periodontal disease; proanthocyanidins

Indexed keywords

CRANBERRY; CYTOKINES; MATRIX METALLOPROTEINASES; PERIODONTAL DISEASE; PROANTHOCYANIDINS;

BACTERIA; COLLAGEN; MUSCULOSKELETAL SYSTEM;

TISSUE;

ANTIINFLAMMATORY AGENT; FLAVONOID; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PROANTHOCYANIDIN;

ARTICLE; CHEMISTRY; CRANBERRY; FRUIT; HUMAN; PERIODONTAL DISEASE;

ANTI-INFLAMMATORY AGENTS; FLAVONOIDS; FRUIT; HUMANS; PERIODONTAL DISEASES; PHYTOCHEMICALS; PLANT EXTRACTS; PROANTHOCYANIDINS; VACCINIUM MACROCARPON;

BACTERIA (MICROORGANISMS); VACCINIUM MACROCARPON;

EID: 84862209489     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf203304v     Document Type: Article

References (94)

1. Guay, D. R. Cranberry and urinary tract infections Drugs 2009, 69, 775-807
2. Perez-Lopez, F. R.; Haya, J.; Chedraui, P. Vaccinium macrocarpon: an interesting option for women with recurrent urinary tract infections and other health benefits J. Obstet. Gynaecol. Res. 2009, 35, 630-639
3. Neto, C. C. Cranberry and its phytochemicals: a review of in vitro anticancer studies J. Nutr. 2007, 137, 186S-193S
4. Ruel, G.; Couillard, C. Evidences of the cardioprotective potential of fruits: the case of cranberries Mol. Nutr. Food Res. 2007, 51, 692-701
5. Pappas, E.; Schaich, K. M. Phytochemicals of cranberries and cranberry products: characterization, potential health effects, and processing stability Crit. Rev. Food Sci. Nutr. 2009, 49, 741-781
6. Dugoua, J. J.; Seely, D.; Perri, D.; Mills, E.; Koren, G. Safety and efficacy of cranberry (Vaccinium macrocarpon) during pregnancy and lactation Can. J. Clin. Pharmacol. 2008, 15, e80-e86
7. Suvarna, R.; Pirmohamed, M.; Henderson, L. Possible interaction between warfarin and cranberry juice BMJ 2003, 327, 1454
8. Lilja, J. J.; Backman, J. T.; Neuvonen, P. J. Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam - probes of CYP2C9, CYP1A2, and CYP3A4 Clin. Pharmacol. Ther. 2007, 81, 833-839
9. Zikria, J.; Goldman, R.; Ansell, J. Cranberry juice and warfarin: when bad publicity trumps science Am. J. Med. 2010, 123, 384-392
10. Hamann, G. L.; Campbell, J. D.; George, C. M. Warfarin-cranberry juice interaction Ann. Pharmacother. 2011, 45, e17
11. Ansell, J.; McDonough, M.; Zhao, Y.; Harmatz, J. S.; Greenblatt, D. J. The absence of an interaction between warfarin and cranberry juice: a randomized, double-blind trial J. Clin. Pharmacol. 2009, 49, 824-830
12. Mellen, C. K.; Ford, M.; Rindone, J. P. Effect of high-dose cranberry juice on the pharmacodynamics of warfarin in patients Br. J. Clin. Pharmacol. 2010, 70, 139-142
13. Bonifait, L.; Grenier, D. Cranberry polyphenols: potential benefits for dental caries and periodontal disease J. Can. Dent. Assoc. 2010, 76, a130
14. Pihlstrom, B. L.; Michalowicz, B. S.; Johnson, N. W. Periodontal diseases Lancet 2005, 366, 1809-1820
15. USDA-ARS National Nutrient Database for Standard Reference (published in National Agricultural Library), 2004; p 17.
16. Masquelier, J.; Michaud, J.; Laparra, J.; Dumon, M. C. [Flavonoids and pycnogenols] Int. J. Vitam. Nutr. Res. 1979, 49, 307-311
17. Rusznyak, S. T.; Szentgyargyi, A. Vitamin P: flavonols as vitamins Nature 1936, 138, 27
18. Gu, L.; Kelm, M. A.; Hammerstone, J. F.; Beecher, G.; Holden, J.; Haytowitz, D.; Gebhardt, S.; Prior, R. L. Concentrations of proanthocyanidins in common foods and estimations of normal consumption J. Nutr. 2004, 134, 613-617
19. Bennick, A. Interaction of plant polyphenols with salivary proteins Crit. Rev. Oral Biol. Med. 2002, 13, 184-196
20. Foo, L. Y.; Lu, Y.; Howell, A. B.; Vorsa, N. The structure of cranberry proanthocyanidins which inhibit adherence of uropathogenic P-fimbriated Escherichia coli in vitro Phytochemistry 2000, 54, 173-181
21. Yan, X.; Murphy, B. T.; Hammond, G. B.; Vinson, J. A.; Neto, C. C. Antioxidant activities and antitumor screening of extracts from cranberry fruit (Vaccinium macrocarpon) J. Agric. Food Chem. 2002, 50, 5844-5849
22. Neto, C. C. Cranberry and blueberry: evidence for protective effects against cancer and vascular diseases Mol. Nutr. Food Res. 2007, 51, 652-664
23. MacLean, M. A.; Scott, B. E.; Deziel, B. A.; Nunnelley, M. C.; Liberty, A. M.; Gottschall-Pass, K. T.; Neto, C. C.; Hurta, R. A. North American cranberry (Vaccinium macrocarpon) stimulates apoptotic pathways in DU145 human prostate cancer cells in vitro Nutr. Cancer 2011, 63, 109-120
24. McKay, D. L.; Blumberg, J. B. Cranberries (Vaccinium macrocarpon) and cardiovascular disease risk factors Nutr. Rev. 2007, 65, 490-502
25. Ruel, G.; Pomerleau, S.; Couture, P.; Lemieux, S.; Lamarche, B.; Couillard, C. Favourable impact of low-calorie cranberry juice consumption on plasma HDL-cholesterol concentrations in men Br. J. Nutr. 2006, 96, 357-364
26. 2+ flux in M1-transfected COS-7 cells J. Alzheimers Dis. 2004, 6, 403-411 (discussion 443-409)
27. Shukitt-Hale, B.; Galli, R. L.; Meterko, V.; Carey, A.; Bielinski, D. F.; McGhie, T.; Joseph, J. A. Dietary supplementation with fruit polyphenolics ameliorates age-related deficits in behavior and neuronal markers of inflammation and oxidative stress Age 2005, 27, 49-57
28. Lipson, S. M.; Sethi, L.; Cohen, P.; Gordon, R. E.; Tan, I. P.; Burdowski, A.; Stotzky, G. Antiviral effects on bacteriophages and rotavirus by cranberry juice Phytomedicine 2007, 14, 23-30
29. Lipson, S. M.; Cohen, P.; Zhou, J.; Burdowski, A.; Stotzky, G. Cranberry cocktail juice, cranberry concentrates, and proanthocyanidins reduce reovirus infectivity titers in African green monkey kidney epithelial cell cultures Mol. Nutr. Food Res. 2007, 51, 752-758
30. Weiss, E. I.; Houri-Haddad, Y.; Greenbaum, E.; Hochman, N.; Ofek, I.; Zakay-Rones, Z. Cranberry juice constituents affect influenza virus adhesion and infectivity Antiviral Res. 2005, 66, 9-12
31. Howell, A. B.; Reed, J. D.; Krueger, C. G.; Winterbottom, R.; Cunningham, D. G.; Leahy, M. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity Phytochemistry 2005, 66, 2281-2291
32. Howell, A. B. Bioactive compounds in cranberries and their role in prevention of urinary tract infections Mol. Nutr. Food Res. 2007, 51, 732-737
33. Burger, O.; Ofek, I.; Tabak, M.; Weiss, E. I.; Sharon, N.; Neeman, I. A high molecular mass constituent of cranberry juice inhibits Helicobacter pylori adhesion to human gastric mucus FEMS Immunol. Med. Microbiol. 2000, 29, 295-301
34. Shmuely, H.; Burger, O.; Neeman, I.; Yahav, J.; Samra, Z.; Niv, Y.; Sharon, N.; Weiss, E.; Athamna, A.; Tabak, M.; Ofek, I. Susceptibility of Helicobacter pylori isolates to the antiadhesion activity of a high-molecular-weight constituent of cranberry Diagn. Microbiol. Infect. Dis. 2004, 50, 231-235
35. Islam, B.; Khan, S. N.; Khan, A. U. Dental caries: from infection to prevention Med. Sci. Monit. 2007, 13, RA196-RA203
36. Steinberg, D.; Feldman, M.; Ofek, I.; Weiss, E. I. Effect of a high-molecular-weight component of cranberry on constituents of dental biofilm J. Antimicrob. Chemother. 2004, 54, 86-89
37. Weiss, E. I.; Lev-Dor, R.; Kashamn, Y.; Goldhar, J.; Sharon, N.; Ofek, I. Inhibiting interspecies coaggregation of plaque bacteria with a cranberry juice constituent [published errata appear in J. Am. Dent. Assoc. 1999, 130 (1), 36; and 1999, 130 (3), 332] J. Am. Dent. Assoc. 1998, 129, 1719-1723
38. Yamanaka, A.; Kimizuka, R.; Kato, T.; Okuda, K. Inhibitory effects of cranberry juice on attachment of oral streptococci and biofilm formation Oral Microbiol. Immunol. 2004, 19, 150-154
39. Weiss, E. I.; Kozlovsky, A.; Steinberg, D.; Lev-Dor, R.; Bar Ness Greenstein, R.; Feldman, M.; Sharon, N.; Ofek, I. A high molecular mass cranberry constituent reduces mutans streptococci level in saliva and inhibits in vitro adhesion to hydroxyapatite FEMS Microbiol. Lett. 2004, 232, 89-92
40. Albandar, J. M.; Rams, T. E. Global epidemiology of periodontal diseases: an overview Periodontol 2000 2002, 29, 7-10
41. Albandar, J. M.; Brunelle, J. A.; Kingman, A. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988-1994 J. Periodontol. 1999, 70, 13-29
42. Stabholz, A.; Soskolne, W. A.; Shapira, L. Genetic and environmental risk factors for chronic periodontitis and aggressive periodontitis Periodontol 2000 2010, 53, 138-153
43. Eley, B. M.; Cox, S. W. Proteolytic and hydrolytic enzymes from putative periodontal pathogens: characterization, molecular genetics, effects on host defenses and tissues and detection in gingival crevice fluid Periodontol 2000 2003, 31, 105-124
44. O'Brien-Simpson, N. M.; Veith, P. D.; Dashper, S. G.; Reynolds, E. C. Antigens of bacteria associated with periodontitis Periodontol 2000 2004, 35, 101-134
45. Feng, Z.; Weinberg, A. Role of bacteria in health and disease of periodontal tissues Periodontol 2000 2006, 40, 50-76
46. 2 secretion as a determinant of periodontal disease expression J. Periodontol. 1993, 64, 432-444
47. Okada, H.; Murakami, S. Cytokine expression in periodontal health and disease Crit. Rev. Oral Biol. Med. 1998, 9, 248-266
48. The American Academy of Periodontology. Epidemiology of periodontal diseases. J. Periodontol. 1996, 67, 935-945.
49. Cobb, C. M. Clinical significance of non-surgical periodontal therapy: an evidence-based perspective of scaling and root planing J. Clin. Periodontol. 2002, 29 (Suppl. 2) 6-16
50. Suvan, J. E. Effectiveness of mechanical nonsurgical pocket therapy Periodontol 2000 2005, 37, 48-71
51. Haffajee, A. D.; Socransky, S. S.; Gunsolley, J. C. Systemic anti-infective periodontal therapy. A systematic review Ann. Periodontol. 2003, 8, 115-181
52. Preshaw, P. M.; Hefti, A. F.; Novak, M. J.; Michalowicz, B. S.; Pihlstrom, B. L.; Schoor, R.; Trummel, C. L.; Dean, J.; Van Dyke, T. E.; Walker, C. B.; Bradshaw, M. H. Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: a multicenter trial J. Periodontol. 2004, 75, 1068-1076
53. Humphrey, L. L.; Fu, R.; Buckley, D. I.; Freeman, M.; Helfand, M. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis J. Gen. Intern. Med. 2008, 23, 2079-2086
54. Bascones-Martinez, A.; Matesanz-Perez, P.; Escribano-Bermejo, M.; Gonzalez-Moles, M. A.; Bascones-Ilundain, J.; Meurman, J. H. Periodontal disease and diabetes - review of the literature Med. Oral Patol. Oral Cir. Bucal 2011, 16 (6) e722-e729
55. Scannapieco, F. A.; Rethman, M. P. The relationship between periodontal diseases and respiratory diseases Dent. Today 2003, 22, 79-83
56. Scannapieco, F. A.; Bush, R. B.; Paju, S. Associations between periodontal disease and risk for nosocomial bacterial pneumonia and chronic obstructive pulmonary disease. A systematic review Ann. Periodontol. 2003, 8, 54-69
57. Gibbs, R. S. The relationship between infections and adverse pregnancy outcomes: an overview Ann. Periodontol. 2001, 6, 153-163
58. La, V. D.; Howell, A. B.; Grenier, D. Anti- Porphyromonas gingivalis and anti-inflammatory activities of zA-type cranberry proanthocyanidins Antimicrob. Agents Chemother. 2010, 54, 1778-1784
59. Andrian, E.; Grenier, D.; Rouabhia, M. In vitro models of tissue penetration and destruction by Porphyromonas gingivalis Infect. Immun. 2004, 72, 4689-4698
60. Bodet, C.; Piche, M.; Chandad, F.; Grenier, D. Inhibition of periodontopathogen-derived proteolytic enzymes by a high-molecular-weight fraction isolated from cranberry J. Antimicrob. Chemother. 2006, 57, 685-690
61. Yamanaka, A.; Kouchi, T.; Kasai, K.; Kato, T.; Ishihara, Y.; Okuda, K. Inhibitory effect of cranberry polyphenol on proteases of periodontopathic bacteria. J. Dent. Res. 2006, 86, Abstract 1078.
62. La, V. D.; Labrecque, J.; Grenier, D. Cytoprotective effect of proanthocyanidin-rich cranberry fraction against bacterial cell wall-mediated toxicity in macrophages and epithelial cells Phytother. Res. 2009, 23, 1449-1452
63. Sorsa, T.; Tjaderhane, L.; Salo, T. Matrix metalloproteinases (MMPs) in oral diseases Oral Dis. 2004, 10, 311-318
64. Nagase, H. Activation mechanisms of matrix metalloproteinases Biol. Chem. 1997, 378, 151-160
65. Kubota, T.; Nomura, T.; Takahashi, T.; Hara, K. Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue Arch. Oral Biol. 1996, 41, 253-262
66. Hannas, A. R.; Pereira, J. C.; Granjeiro, J. M.; Tjaderhane, L. The role of matrix metalloproteinases in the oral environment Acta Odontol. Scand. 2007, 65, 1-13
67. Jotwani, R.; Eswaran, S. V.; Moonga, S.; Cutler, C. W. MMP-9/TIMP-1 imbalance induced in human dendritic cells by Porphyromonas gingivalis FEMS Immunol. Med. Microbiol. 2010, 58, 314-321
68. Soell, M.; Elkaim, R.; Tenenbaum, H. Cathepsin C, matrix metalloproteinases, and their tissue inhibitors in gingiva and gingival crevicular fluid from periodontitis-affected patients J. Dent. Res. 2002, 81, 174-178
69. Birkedal-Hansen, H. Role of matrix metalloproteinases in human periodontal diseases J. Periodontol. 1993, 64, 474-484
70. Ramamurthy, N. S.; Xu, J. W.; Bird, J.; Baxter, A.; Bhogal, R.; Wills, R.; Watson, B.; Owen, D.; Wolff, M.; Greenwald, R. A. Inhibition of alveolar bone loss by matrix metalloproteinase inhibitors in experimental periodontal disease J. Periodontal Res. 2002, 37, 1-7
71. Bellosta, S.; Dell'Agli, M.; Canavesi, M.; Mitro, N.; Monetti, M.; Crestani, M.; Verotta, L.; Fuzzati, N.; Bernini, F.; Bosisio, E. Inhibition of metalloproteinase-9 activity and gene expression by polyphenolic compounds isolated from the bark of Tristaniopsis calobuxus (Myrtaceae) Cell. Mol. Life Sci. 2003, 60, 1440-1448
72. Bodet, C.; Chandad, F.; Grenier, D. Inhibition of host extracellular matrix destructive enzyme production and activity by a high-molecular-weight cranberry fraction J. Periodontal Res. 2007, 42, 159-168
73. La, V. D.; Howell, A. B.; Grenier, D. Cranberry proanthocyanidins inhibit MMP production and activity J. Dent. Res. 2009, 88, 627-632
74. Gabison, E. E.; Hoang-Xuan, T.; Mauviel, A.; Menashi, S. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair Biochimie 2005, 87, 361-368
75. Feldman, M.; La, V. D.; Bedran, T.; Spolidorio, D.; Grenier, D. Porphyromonas gingivalis -mediated shedding of extracellular matrix metalloproteinase inducer (EMMPRIN) by oral epithelial cells: a potential role in inflammatory periodontal disease Microbes Infect. 2011, 13, 1261-1269
76. Zappa, U.; Reinking-Zappa, M.; Graf, H.; Espeland, M. Cell populations and episodic periodontal attachment loss in humans J. Clin. Periodontol. 1991, 18, 508-515
77. Kornman, K. S.; Page, R. C.; Tonetti, M. S. The host response to the microbial challenge in periodontitis: assembling the players Periodontol 2000 1997, 14, 33-53
78. Meikle, M. C.; Atkinson, S. J.; Ward, R. V.; Murphy, G.; Reynolds, J. J. Gingival fibroblasts degrade type I collagen films when stimulated with tumor necrosis factor and interleukin 1: evidence that breakdown is mediated by metalloproteinases J. Periodontal Res. 1989, 24, 207-213
79. Richards, D.; Rutherford, R. B. Interleukin-1 regulation of procollagenase mRNA and protein in periodontal fibroblasts in vitro J. Periodontal Res. 1990, 25, 222-229
80. Mochan, E.; Armor, L.; Sporer, R. Interleukin 1 stimulation of plasminogen activator production in cultured gingival fibroblasts J. Periodontal Res. 1988, 23, 28-32
81. Hou, L. T.; Liu, C. M.; Rossomando, E. F. Crevicular interleukin-1 β in moderate and severe periodontitis patients and the effect of phase I periodontal treatment J. Clin. Periodontol. 1995, 22, 162-167
82. Bodet, C.; Chandad, F.; Grenier, D. Anti-inflammatory activity of a high-molecular-weight cranberry fraction on macrophages stimulated by lipopolysaccharides from periodontopathogens J. Dent. Res. 2006, 85, 235-239
83. Luster, A. D. Chemokines - chemotactic cytokines that mediate inflammation N. Engl. J. Med. 1998, 338, 436-445
84. Wassenaar, A.; Snijders, A.; Abraham-Inpijn, L.; Kapsenberg, M. L.; Kievits, F. Antigen-presenting properties of gingival fibroblasts in chronic adult periodontitis Clin. Exp. Immunol. 1997, 110, 277-284
85. Dongari-Bagtzoglou, A. I.; Ebersole, J. L. Production of inflammatory mediators and cytokines by human gingival fibroblasts following bacterial challenge J Periodontal Res 1996, 31, 90-98
86. Bodet, C.; Chandad, F.; Grenier, D. Cranberry components inhibit interleukin-6, interleukin-8, and prostaglandin E2 production by lipopolysaccharide-activated gingival fibroblasts Eur. J. Oral Sci. 2007, 115, 64-70
87. Teitelbaum, S. L. Bone resorption by osteoclasts Science 2000, 289, 1504-1508
88. Bodet, C.; Chandad, F.; Grenier, D. [Pathogenic potential of Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia, the red bacterial complex associated with periodontitis] Pathol. Biol. (Paris) 2007, 55, 154-162
89. Cochran, D. L. Inflammation and bone loss in periodontal disease J. Periodontol. 2008, 79, 1569-1576
90. Birkedal-Hansen, H. Role of cytokines and inflammatory mediators in tissue destruction J. Periodontal Res. 1993, 28, 500-510
91. McCauley, L. K.; Nohutcu, R. M. Mediators of periodontal osseous destruction and remodeling: principles and implications for diagnosis and therapy J. Periodontol. 2002, 73, 1377-1391
92. Tanabe, S.; Santos, J.; La, V. D.; Howell, A. B.; Grenier, D. A-Type cranberry proanthocyanidins inhibit the RANKL-dependent differentiation and function of human osteoclasts Molecules 2011, 16, 2365-2374
93. Trzeciakiewicz, A.; Habauzit, V.; Horcajada, M. N. When nutrition interacts with osteoblast function: molecular mechanisms of polyphenols Nutr. Res. Rev. 2009, 22, 68-81
94. Hardcastle, A. C.; Aucott, L.; Reid, D. M.; Macdonald, H. M. Associations between dietary flavonoid intakes and bone health in a Scottish population J. Bone Miner. Res. 2011, 26, 941-947